Innate Pharma IPHA Ratios (2017-2025)

NASDAQ IPHA
$2.27 +0.18 (+8.65%)
As of: Aug 21, 2026 · 3:27 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Ratios Dec2017 Dec2018 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Profitability
EBT Margin (Quarter) -30.10%-1.48%-394.86%-0.03%1.61%-14.59%-298.61%-391.94%-1,764.51%
EBIT Margin (Quarter) -37.31%-13.52%-394.86%-0.03%-1.13%-18.12%-317.29%-423.44%-1,876.46%
EBITDA Margin (Quarter) -37.31%-13.52%-394.86%-0.03%-1.13%-18.12%-317.29%-423.44%-1,876.46%
Operating Margin (Quarter) -394.86%-1.13%-317.29%
Net Margin (Quarter) -30.10%-112.47%887.05%-0.42%0.11%1.61%-14.59%-298.61%-391.94%
FCF Margin (Quarter) 1.84%1.62%7.67%0.01%0.00%0.01%0.68%3.41%3.10%5.02%
Efficiency
Assets Average (Quarter) 0.41B166.76B166.72B0.34B0.31B0.30B0.25B0.21B0.20B0.18B0.14B0.11B0.09B
Invested Capital (Quarter) 0.01B0.02B0.02B0.02B0.02B0.02B0.05B0.05B0.04B0.04B0.04B0.04B0.03B0.03B0.03B
Asset Utilization Ratio (Quarter) 0.06201.93241.40250.18288.290.830.91
Leverage & Solvency
Interest Coverage Ratio (Quarter) 5.171.1211.970.00B0.415.1312.7513.459.0716.76
Debt Ratio (Quarter) 0.020.010.050.060.060.060.170.230.210.200.230.230.280.290.36
Times Interest Earned (Quarter) 5.171.1211.970.00B0.415.1312.7513.459.0716.76
Valuation
Enterprise Value (Quarter) -0.14B-0.19B-0.24B-147.74B-0.18B-0.14B-0.14B-0.13B-0.10B-0.10B-0.10B-0.10B-0.09B-0.07B-0.04B
Return Ratios
Return on Sales (Quarter) 0.00%-0.01%-0.01%0.00%0.00%0.00%0.00%-0.03%-0.04%-0.01%
Return on Capital Employed (Quarter) -26.47%-46.68%-53.15%-60.66%-51.27%-41.33%-90.85%-158.15%-377.03%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%